| Patient | Phillis Wheatley |
|---|---|
| Date of birth | 1753-07-01 |
| Identifiers | MRN HR-EN015-SYN-TD; SSN (made up) 000-15-3360 |
| Document date | 2026-11-01 |
| Author | Abena Hartley-Okonkwo, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
New patient visit for three months of winter wheeze, cough and breathlessness in a 19-year-old woman called asthmatic since childhood and never tested: examination, chest X-ray, blood count, tuberculosis and pregnancy tests, and planning of lung function testing; trauma-informed social history. Concerns: Her chest is worse every winter, and cough at night keeps her from sleeping and writing; She may soon travel by sea to see her book published abroad, and wants to be well enough to go; She wants her care to be her own: her consent, her information, and her decisions. [S]
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Budesonide-formoterol 160/4.5 mcg inhaler as needed only (GINA track 1, step 2, anti-inflammatory reliever): one inhalation whenever needed for symptoms or before exercise in the cold, no more than 12 inhalations a day | One inhalation as needed | Respiratory tract route | 1773-02-23 to 1773-09-21 | completed | S |
| Prednisone 20 mg oral tablet, standby course for the sea journey and the summer away: two tablets (40 mg) each morning for five days, to start only as her action plan directs | 40 mg each morning for five days if the action plan directs | Oral route | 1773-04-06 to 1773-10-26 | stopped | S |
| Meclizine 25 mg oral tablet, one tablet an hour before sailing and then once daily as needed for seasickness | One tablet daily as needed at sea | Oral route | 1773-04-06 to 1773-09-21 | completed | S |
| Folic acid 0.4 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1773-04-27 | active | S |
| Budesonide-formoterol 160/4.5 mcg inhaler as maintenance and reliever (GINA track 1, step 3): one inhalation twice daily and one inhalation as needed, no more than 12 inhalations a day | One inhalation twice daily plus one as needed | Respiratory tract route | 1773-09-21 | active | S |
| Procedure | Dates | Status | Evidence |
|---|---|---|---|
| Chest X-ray, posteroanterior and lateral: lungs clear and not hyperinflated; no consolidation, hilar enlargement, cavity, scarring or effusion; heart size normal | 1773-02-09 to 1773-02-09 | completed | S |
| Spirometry before and 15 minutes after albuterol 400 mcg, with FeNO, interpreted with GLI Global race-neutral equations: FEV1 2.24 L (83 percent predicted) rising to 2.57 L (+330 mL, +15 percent); FEV1/FVC 0.72 before (below the lower limit of normal of 0.75) and 0.80 after; FeNO 38 ppb. Reversible airflow obstruction: asthma | 1773-02-23 to 1773-02-23 | completed | S |
| Written asthma action plan, given and explained: green zone use the reliever as needed; yellow zone (more symptoms, waking, or peak flow below 80 percent of her best) use more reliever inhalations up to 12 a day and call the clinic; red zone (peak flow below 50 percent, cannot speak in sentences, or no relief) emergency care. Peak flow meter given; zones to be set from her personal best | 1773-02-23 to 1773-02-23 | completed | S |
| Inhaler technique with her new pressurized inhaler and a spacer: taught and checked by teach-back; correct | 1773-02-23 to 1773-02-23 | completed | S |
| Asthma action plan updated for travel: peak flow zones set from her personal best of 400 L/min (green above 320, yellow 200 to 320, red below 200); instructions for the standby prednisone course and for finding care at sea and abroad; a printed medical summary | 1773-04-06 to 1773-04-06 | completed | S |
| Advance care planning conversation, about 16 minutes, with her consent | 1773-04-27 to 1773-04-27 | completed | S |
| Spirometry before bronchodilator after recovery: FEV1 2.45 L (91 percent predicted); FEV1/FVC 0.78; FeNO 24 ppb | 1773-10-26 to 1773-10-26 | completed | S |
| Asthma action plan updated for maintenance-and-reliever therapy through the winter (green above 320 L/min, yellow 200 to 320, red below 200) | 1773-10-26 to 1773-10-26 | completed | S |
| Date | Vaccine | Status | Evidence |
|---|---|---|---|
| 1765-09-04 | Tdap vaccine (from her school record) | completed | S |
| 1773-02-23 | Influenza vaccine, this season | completed | S |
| 1773-02-23 | COVID-19 mRNA vaccine, this season's formula | completed | S |
| 1773-02-23 | Pneumococcal conjugate vaccine PCV20 | completed | S |
| 1773-04-27 | Human papillomavirus vaccine (9-valent), dose 1 of 3 | completed | S |
| 1773-04-27 | Hepatitis B vaccine (HepB-CpG), dose 1 of 2 | completed | S |
| 1773-10-26 | Hepatitis B vaccine (HepB-CpG), dose 2 of 2 | completed | S |
| 1773-10-26 | Human papillomavirus vaccine (9-valent), dose 2 of 3 | completed | S |
| 1773-10-26 | Influenza vaccine, the new season | completed | S |
| 1773-10-26 | COVID-19 mRNA vaccine, the new season's formula | completed | S |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| 1761 | Described as a slender, frail child on her arrival in Boston at about seven, and by one reference work as asthmatic; no symptoms, triggers or treatment recorded | D (CLM-0003) |
No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.
| Concern | Status | Evidence |
|---|---|---|
| Her chest is worse every winter, and cough at night keeps her from sleeping and writing | active | S |
| She may soon travel by sea to see her book published abroad, and wants to be well enough to go | active | S |
| She wants her care to be her own: her consent, her information, and her decisions | active | S |
Most recent measures: Hemoglobin [Mass/volume] in Blood 12.6 on 1773-02-09; Leukocytes [#/volume] in Blood by Automated count 7.2 on 1773-02-09; Eosinophils [#/volume] in Blood by Automated count 0.38 on 1773-02-09; Platelets [#/volume] in Blood by Automated count 284 on 1773-02-09; Total score [ACT] 20 on 1773-10-26; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 1773-10-26; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 4 on 1773-04-27; Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 3 on 1773-04-27; Maximum expiratory gas flow Respiratory system airway by Peak flow meter 385 on 1773-10-26; FEV1 --pre bronchodilation 2.45 on 1773-10-26; FEV1 --post bronchodilation 2.57 on 1773-02-23; FEV1 measured/predicted 91 on 1773-10-26; FEV1/FVC 0.78 on 1773-10-26; FEV1/FVC --post bronchodilation 0.8 on 1773-02-23; Fractional concentration of exhaled nitric oxide 24 on 1773-10-26; IgE [Units/volume] in Serum or Plasma 165 on 1773-02-23 [S]
Strengths and supports: engagement in care [S]
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Wheeze, cough and breathlessness this winter, for about three months: symptoms on three or four days a week, waking with cough and a tight chest about twice a month, breathless climbing the hill streets in cold air; worse with cold wind, kitchen and fireplace smoke, and colds; called a weak chest and asthma since childhood but never tested or treated. Asthma to be confirmed with spirometry before and after bronchodilator and FeNO | resolved | confirmed | R06.2 | S — Synthetic presenting problem anchored to her documented frail, asthmatic childhood. Superseded by the diagnosis at the second visit. |
| Asthma, confirmed, mild persistent: variable airflow obstruction (FEV1/FVC 0.72, below the lower limit of normal, rising to 0.80 after bronchodilator; FEV1 2.24 L, 83 percent predicted, rising 330 mL or 15 percent); type 2 inflammation (FeNO 38 ppb, blood eosinophils 0.38 x10^3/uL, total IgE 165, house dust mite sensitization); tuberculosis infection test negative and chest X-ray clear. Triggers: cold air, kitchen and fireplace smoke, colds | active | confirmed | J45.30 | S — Synthetic modern confirmation linked to her documented frail, asthmatic childhood and her own later descriptions of asthma. |
| Asthma exacerbation with a cold a week after returning from abroad: three days of wheeze, chest tightness and waking at night despite six to eight reliever inhalations a day; peak flow 270 L/min (68 percent of her best of 400), oxygen saturation 96 percent; 330 L/min after treatment in clinic; treated without oral corticosteroids; resolved | resolved | confirmed | J45.31 | S — Synthetic exacerbation anchored to her own letter describing a cold and asthma after her return; the clinical details are synthetic. |
| Prone to seasickness on boat trips; meclizine for the sea crossing; resolved on her return | resolved | confirmed | T75.3XXA | S — Synthetic travel-related problem. |
| Pregnancy planning: not sexually active and no contraception wanted now; she may wish to have children one day; folic acid by her choice, and asthma care planned before and during any pregnancy | active | confirmed | Z31.69 | S — Synthetic reproductive health counselling; not a claim about her real life. |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1773-02-09 | Hemoglobin [Mass/volume] in Blood | 12.6 | g/dL | 12-15.5 g/dL | Normal | S |
| 1773-02-09 | Leukocytes [#/volume] in Blood by Automated count | 7.2 | 10*3/uL | 4-11 10*3/uL | Normal | S |
| 1773-02-09 | Eosinophils [#/volume] in Blood by Automated count | 0.38 | 10*3/uL | 0-0.5 10*3/uL | Normal | S |
| 1773-02-09 | Platelets [#/volume] in Blood by Automated count | 284 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 1773-02-09 | Total score [ACT] | 15 | {score} | S | ||
| 1773-02-09 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 1 | {score} | S | ||
| 1773-04-27 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 4 | {score} | S | ||
| 1773-04-27 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 3 | {score} | S | ||
| 1773-09-21 | Maximum expiratory gas flow Respiratory system airway by Peak flow meter | 270 | L/min | 80 percent of her personal best of 400 L/min | Low | S |
| 1773-02-23 | FEV1 --pre bronchodilation | 2.24 | L | Lower limit of normal; predicted 2.70 L; lower limit of normal 2.17 L (GLI Global race-neutral equations) | Normal | S |
| 1773-02-23 | FEV1 --post bronchodilation | 2.57 | L | Lower limit of normal; predicted 2.70 L; lower limit of normal 2.17 L (GLI Global race-neutral equations) | Normal | S |
| 1773-02-23 | FEV1 measured/predicted | 83 | % | GLI Global race-neutral equations | Normal | S |
| 1773-02-23 | FEV1/FVC | 0.72 | {ratio} | Lower limit of normal for her age (GLI Global) | Low | S |
| 1773-02-23 | FEV1/FVC --post bronchodilation | 0.8 | {ratio} | Lower limit of normal for her age (GLI Global) | Normal | S |
| 1773-02-23 | Fractional concentration of exhaled nitric oxide | 38 | [ppb] | Above 50 ppb high; 25 to 50 intermediate (ATS) | High | S |
| 1773-02-23 | IgE [Units/volume] in Serum or Plasma | 165 | [IU]/mL | <=100 [IU]/mL | High | S |
| 1773-02-23 | Total score [ACT] | 16 | {score} | S | ||
| 1773-04-06 | Total score [ACT] | 21 | {score} | S | ||
| 1773-04-06 | Maximum expiratory gas flow Respiratory system airway by Peak flow meter | 400 | L/min | 80 percent of her personal best of 400 L/min | Normal | S |
| 1773-10-26 | Total score [ACT] | 20 | {score} | S | ||
| 1773-10-26 | FEV1 --pre bronchodilation | 2.45 | L | Lower limit of normal; predicted 2.70 L; lower limit of normal 2.17 L (GLI Global race-neutral equations) | Normal | S |
| 1773-10-26 | FEV1 measured/predicted | 91 | % | GLI Global race-neutral equations | Normal | S |
| 1773-10-26 | FEV1/FVC | 0.78 | {ratio} | Lower limit of normal for her age (GLI Global) | Normal | S |
| 1773-10-26 | Fractional concentration of exhaled nitric oxide | 24 | [ppb] | Above 50 ppb high; 25 to 50 intermediate (ATS) | Normal | S |
| 1773-10-26 | Maximum expiratory gas flow Respiratory system airway by Peak flow meter | 385 | L/min | 80 percent of her personal best of 400 L/min | Normal | S |
| 1773-10-26 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1773-02-09 | Body height | 152 | cm | S |
| 1773-02-09 | Body weight | 45.6 | kg | S |
| 1773-02-09 | Body mass index (BMI) [Ratio] | 19.7 | kg/m2 | S |
| 1773-02-09 | Systolic blood pressure | 104 | mm[Hg] | S |
| 1773-02-09 | Diastolic blood pressure | 66 | mm[Hg] | S |
| 1773-02-09 | Heart rate | 86 | /min | S |
| 1773-02-09 | Respiratory rate | 18 | /min | S |
| 1773-02-09 | Body temperature | 36.7 | Cel | S |
| 1773-02-09 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 1773-02-23 | Body height | 152 | cm | S |
| 1773-02-23 | Body weight | 45.8 | kg | S |
| 1773-02-23 | Body mass index (BMI) [Ratio] | 19.8 | kg/m2 | S |
| 1773-02-23 | Systolic blood pressure | 106 | mm[Hg] | S |
| 1773-02-23 | Diastolic blood pressure | 66 | mm[Hg] | S |
| 1773-02-23 | Heart rate | 82 | /min | S |
| 1773-02-23 | Respiratory rate | 16 | /min | S |
| 1773-02-23 | Body temperature | 36.6 | Cel | S |
| 1773-02-23 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1773-04-06 | Body height | 152 | cm | S |
| 1773-04-06 | Body weight | 46.4 | kg | S |
| 1773-04-06 | Body mass index (BMI) [Ratio] | 20.1 | kg/m2 | S |
| 1773-04-06 | Systolic blood pressure | 104 | mm[Hg] | S |
| 1773-04-06 | Diastolic blood pressure | 64 | mm[Hg] | S |
| 1773-04-06 | Heart rate | 76 | /min | S |
| 1773-04-06 | Respiratory rate | 14 | /min | S |
| 1773-04-06 | Body temperature | 36.6 | Cel | S |
| 1773-04-06 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 1773-04-27 | Body height | 152 | cm | S |
| 1773-04-27 | Body weight | 46.6 | kg | S |
| 1773-04-27 | Body mass index (BMI) [Ratio] | 20.2 | kg/m2 | S |
| 1773-04-27 | Systolic blood pressure | 102 | mm[Hg] | S |
| 1773-04-27 | Diastolic blood pressure | 64 | mm[Hg] | S |
| 1773-04-27 | Heart rate | 74 | /min | S |
| 1773-04-27 | Respiratory rate | 14 | /min | S |
| 1773-04-27 | Body temperature | 36.6 | Cel | S |
| 1773-04-27 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 1773-09-21 | Body height | 152 | cm | S |
| 1773-09-21 | Body weight | 47.2 | kg | S |
| 1773-09-21 | Body mass index (BMI) [Ratio] | 20.4 | kg/m2 | S |
| 1773-09-21 | Systolic blood pressure | 108 | mm[Hg] | S |
| 1773-09-21 | Diastolic blood pressure | 68 | mm[Hg] | S |
| 1773-09-21 | Heart rate | 98 | /min | S |
| 1773-09-21 | Respiratory rate | 20 | /min | S |
| 1773-09-21 | Body temperature | 37.6 | Cel | S |
| 1773-09-21 | Oxygen saturation in Arterial blood by Pulse oximetry | 96 | % | S |
| 1773-10-26 | Body height | 152 | cm | S |
| 1773-10-26 | Body weight | 47.6 | kg | S |
| 1773-10-26 | Body mass index (BMI) [Ratio] | 20.6 | kg/m2 | S |
| 1773-10-26 | Systolic blood pressure | 104 | mm[Hg] | S |
| 1773-10-26 | Diastolic blood pressure | 66 | mm[Hg] | S |
| 1773-10-26 | Heart rate | 74 | /min | S |
| 1773-10-26 | Respiratory rate | 14 | /min | S |
| 1773-10-26 | Body temperature | 36.5 | Cel | S |
| 1773-10-26 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Purpose | Status | Provenance |
|---|---|---|---|
| 1773-02-09 | New patient visit for three months of winter wheeze, cough and breathlessness in a 19-year-old woman called asthmatic since childhood and never tested: examination, chest X-ray, blood count, tuberculosis and pregnancy tests, and planning of lung function testing; trauma-informed social history | finished | S |
| 1773-02-23 | Diagnosis visit: spirometry with bronchodilator response and FeNO with the pulmonology consultation; asthma confirmed; start of as-needed budesonide-formoterol (GINA track 1); action plan; vaccines | finished | S |
| 1773-04-06 | Six-week asthma review: control, technique, personal best peak flow, triggers, and planning for a long sea journey and a summer away | finished | S |
| 1773-10-26 | Asthma review after an exacerbation with a cold on her return from abroad: control, repeat spirometry and FeNO, the winter plan, completion of vaccines, and her changed circumstances | finished | S |
| 1773-04-27 | Periodic preventive visit before a long sea journey | finished | S |
| 1773-09-21 | Same-day sick visit for asthma with a cold after returning from abroad | finished | S |
| Intervention | Status | Guideline | Provenance |
|---|---|---|---|
| Pulmonology consultation in two weeks with spirometry before and after bronchodilator and FeNO, to confirm or refute asthma, exclude other chest disease, and plan treatment and preparation for travel | completed | GL-GINA-2025, GL-NAEPP-2020, GL-CMID-2026 | S |
| Work-up of wheeze and cough: chest X-ray, blood count with eosinophils, interferon-gamma release assay for tuberculosis infection (born in a country where tuberculosis is common), and a urine pregnancy test before treatment; no inhaler is started before testing unless symptoms worsen | completed | GL-GINA-2025, GL-USPSTF-LTBI-2023 | S |
| Trauma-informed, patient-centred care: seen alone for part of every visit; consent, information and results to her alone, through her own contact details; no instructions about her care accepted from the household; private screening for safety and exploitation at each visit, with resources and social work offered and her decisions respected | completed | GL-ACOG-TRAFFICKING-2019, GL-USPSTF-IPV-2025 | S |
| Equity safeguards: spirometry read with race-neutral GLI Global equations, plain explanation of every result, and attention to the higher asthma burden carried by Black women | completed | GL-ATS-RACE-2023, GL-MMWR-ASTHMA-2021 | S |
| GINA track 1, step 2: as-needed low-dose budesonide-formoterol (no albuterol-only reliever), a written action plan with peak flow zones, technique checks and trigger reduction (kitchen ventilation, avoiding fireplace smoke, a scarf in cold wind, mite-proof bedding); review six weeks after starting and within a week of any exacerbation | completed | GL-GINA-2025, GL-NAEPP-2020, GL-CMID-2026 | S |
| Vaccines for an adult with asthma: influenza and COVID-19 each season, and PCV20 once | completed | GL-CDC-IMZ-MC-2026, GL-CDC-IMZ-2026 | S |
| Travel plan for a long sea journey: two inhalers and a spacer, an updated action plan, a standby five-day prednisone course with clear start rules, meclizine for seasickness, an aired cabin away from smoke, a printed medical summary and contact with the clinic by message | completed | GL-GINA-2025, GL-CDC-YB-MOTION | S |
| Contraception and pregnancy planning on her terms: information on every method (all suitable with asthma), folic acid 0.4 mg daily by her choice, and asthma review before and during any pregnancy with budesonide as the preferred inhaled steroid and the controller never stopped | completed | GL-CDC-MEC-2024, GL-ACOG-ASTHMA-2008, GL-USPSTF-FOLIC-2023 | S |
| After the exacerbation: GINA track 1 step 3, budesonide-formoterol one inhalation twice daily and as needed through the winter, with a step-down to as-needed treatment in the spring if she stays well | completed | GL-GINA-2025, GL-CMID-2026 | S |
| Social work, at her request, for health coverage in her own name, income and housing after she gained her freedom | completed | GL-ACOG-TRAFFICKING-2019 | S |
| Goal | Target | Status | Outcome | Provenance |
|---|---|---|---|---|
| A confirmed diagnosis within two weeks: spirometry with bronchodilator response and FeNO, with tuberculosis excluded | 1773-02-23 | completed | Asthma confirmed by a 330 mL (15 percent) bronchodilator response and FeNO 38 ppb; tuberculosis test negative and chest X-ray clear, two weeks after the first visit | S |
| Asthma Control Test 20 or more with no night waking | 1773-04-06 | completed | Asthma Control Test 21 and no night waking six weeks after starting treatment; 20 after the exacerbation | S |
| Correct inhaler technique and a written action plan she can use at home and at sea | 1773-04-06 | completed | Technique correct at every visit; plan used during the exacerbation | S |
| Well enough to make the sea journey and spend the summer away | 1773-09-21 | completed | Travelled and stayed well all summer without the standby prednisone | S |
| No exacerbation needing an oral corticosteroid | 1773-10-26 | completed | Achieved: one exacerbation with a cold, managed with extra budesonide-formoterol and a step-up, without prednisone | S |
| Hepatitis B and HPV vaccination complete | 1774-01-25 | active | Hepatitis B series complete; HPV dose 3 due | S |